Reportedly, IRF2 is a direct target of miR-1290, and up-modulation of IRF2 can partially mitigate the promotion of NSCLC cell proliferation and invasion caused by miR-1290 overexpression, suggesting IRF2 is a tumor suppressor in NSCLC [8]. This evidence concerns the gene IRF2 and non-small cell lung carcinoma.